Old blood pressure pill could be first to slow Parkinson's
NCT ID NCT07288450
Summary
This study is testing if terazosin, an existing blood pressure drug, can slow the progression of Parkinson's disease by boosting energy levels in brain cells. It will involve 100 people with early-stage Parkinson's who will take either terazosin or a placebo for 6 months. Researchers will measure changes in blood energy markers and, in some participants, brain scans to see if the drug engages its intended target.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.